Michael F. Berger

Also affiliated with Cornell University, New York Oncology Hematology, Molecular Oncology (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

14.8Author DataRank

Indexed papers

7in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 7 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467

Top 4%

5.0DataRank

Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

Papers

Driven by 118 papers — median percentile 83. Top paper: “Improved prediction of immune checkpoint blockade efficacy across multiple cancer types”.

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Nature Biotechnology(2021)10.1038/s41587-021-01070-8

N/A

7.3DataRank · unranked

272 citations

Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee +29 more

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467

Top 4%

5.0DataRank

Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab124

Top 4%

5.0DataRank

Top 4%199 citations

Walid K. Chatila, Rona Yaeger, Henry Walch, Gustavo dos Santos Fernandes, Asha Krishnan +42 more

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet(2023)10.1016/s0140-6736(23)01857-3

N/A

4.7DataRank · unranked

264 citations

Jonathan T. Yang, Juber Patel, Annemarie F. Shepherd, Juliana Eng, Randy Yeh +44 more

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

Nature Medicine(2024)10.1038/s41591-024-03040-4

N/A

2.1DataRank · unranked

107 citations

Minita Shah, Amanda Frydendahl, Daniel Halmos, Cole C. Khamnei, Nadia Øgaard +56 more

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00358-3

N/A

1.5DataRank · unranked

45 citations

Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi +25 more

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes

Cancer(2021)10.1002/cncr.33812

Top 17%

1.2DataRank

Top 17%42 citations

Catherine O’Connor, Joanne F. Chou, Marinela Capanu, Wungki Park, Chaitanya Bandlamudi +19 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

Science(2011)10.1126/science.1208130

N/A

1.2DataRank · unranked

2533 citations

Ann Marie Egloff, Aaron D. Tward, Aleksandar D. Kostic, Kristian Cibulskis, Sachet A. Shukla +38 more

The genomic complexity of primary human prostate cancer

Nature(2011)10.1038/nature09744

N/A

1.1DataRank · unranked

1250 citations

Michael S. Lawrence, Francesca Demichelis, Timothy R. Dreszer, Kristian Cibulskis, Sachet A. Shukla +36 more

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Cell(2020)10.1016/j.cell.2020.07.009

N/A

1.1DataRank · unranked

1205 citations

Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez +95 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.986DataRank · unranked

717 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4707

Top 22%

0.924DataRank

Top 22%38 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-20935-9

N/A

0.920DataRank · unranked

459 citations

Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli +24 more

The association between tumor mutational burden and prognosis is dependent on treatment context

Nature Genetics(2021)10.1038/s41588-020-00752-4

N/A

0.836DataRank · unranked

263 citations

Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel +22 more

Development and evaluation of RNA-seq methods

Genome Biology(2010)10.1186/gb-2010-11-s1-p26

N/A

0.833DataRank · unranked

9 citations

Xian Adiconis, Moran Yassour, Dawn Thompson, Mitchell Guttman, Lin Fan +7 more

Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs

JCO Precision Oncology(2020)10.1200/po.20.00166

Top 25%

0.821DataRank

Top 25%17 citations

Mark T.A. Donoghue, François Audenet, Nathan C. Wong, Eugene J. Pietzak, Craig M. Bielski +25 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

Cancer Cell(2022)10.1016/j.ccell.2022.08.022

N/A

0.717DataRank · unranked

118 citations

Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl +27 more

Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.022

N/A

0.695DataRank · unranked

102 citations

Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon +14 more

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3909

N/A

0.627DataRank · unranked

16 citations

Li‐Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson +19 more

Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0546

N/A

0.587DataRank · unranked

49 citations

Antonio Marra, Pier Selenica, Eric Rios‐Doria, Amir Momeni Boroujeni, Michael F. Berger +12 more

Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants

Cancer(2022)10.1002/cncr.34434

N/A

0.571DataRank · unranked

44 citations

Anna Maio, Yelena Kemel, Erin Salo‐Mullen, Margaret Sheehan, Prince Ray Tejada +22 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0.524DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.17.476508

N/A

0.434DataRank · unranked

17 citations

Minita Shah, Nadia Øgaard, Cole C. Khamnei, Amanda Frydendahl, Aditya Deshpande +37 more

Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study

JCO Precision Oncology(2021)10.1200/po.20.00184

N/A

0.365DataRank · unranked

5 citations

Jonathan Reichel, Jiabin Tang, Juber Patel, Fanli Meng, Duygu Selcuklu +15 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0.345DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial

Research Square(2025)10.21203/rs.3.rs-7334701/v1

N/A

0.214DataRank · unranked

3 citations

Catherine O’Connor, Joanne F. Chou, Marc Hilmi, Zeynep Tarcan, Carly Schwartz +61 more

Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.8599

N/A

0.208DataRank · unranked

3 citations

Daniel M. Muldoon, Christopher A. Febres‐Aldana, Christina J. Falcon, Amanda Pupo, Chaitanya Bandlamudi +6 more

Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance)

European Urology Open Science(2025)10.1016/j.euros.2025.03.009

N/A

0.208DataRank · unranked

3 citations

Karissa Whiting, Ronak Shah, Karla V. Ballman, Susan Halabi, Ashley Marie Regazzi +10 more

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies

npj Breast Cancer(2021)10.1038/s41523-021-00334-5

N/A

0DataRank · unranked

15 citations

Pier Selenica, Yingjie Zhu, Helen Won, Michael F. Berger, Lorenzo Ferrando +9 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0DataRank · unranked

58 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9009

N/A

0DataRank · unranked

19 citations

Emily S. Lebow, Yonina R. Murciano‐Goroff, Gowtham Jayakumaran, Ronglai Shen, A. Rose Brannon +15 more

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4526

N/A

0DataRank · unranked

5 citations

Jatin Gandhi, Min Yuen Teo, Michael Lattanzi, Samuel A. Funt, David H. Aggen +14 more

Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16519

N/A

0DataRank · unranked

0 citations

Min Yuen Teo, Samuel A. Funt, Chung‐Han Lee, David H. Aggen, Neha Ratna +11 more

BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3012

N/A

0DataRank · unranked

0 citations

Alison M. Schram, Ezra Y. Rosen, Yelena Y. Janjigian, Michael F. Berger, Mark T.A. Donoghue +3 more

ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.14.464262

N/A

0DataRank · unranked

0 citations

Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng +19 more

Cancer-Causative Mutations Occurring in Early Embryogenesis

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1110

N/A

0DataRank · unranked

36 citations

Ryan Ptashkin, David N. Brown, Fatemeh Derakhshan, Pier Selenica, Edaise M. da Silva +31 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights

Nature Communications(2021)10.1038/s41467-021-27106-w

N/A

0DataRank · unranked

44 citations

Gregory Knapp, Avinash Sharma, Walid K. Chatila, Olukayode Arowolo, Olalekan Olasehinde +35 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0DataRank · unranked

140 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA

Nature Metabolism(2021)10.1038/s42255-021-00378-8

N/A

0DataRank · unranked

113 citations

Minsoo Kim, Walid K. Chatila, Konnor La, A. Ari Hakimi, Michael F. Berger +4 more

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Nature Communications(2022)10.1038/s41467-022-28848-x

N/A

0DataRank · unranked

114 citations

Helen Won, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong +27 more

Clonal hematopoiesis is associated with risk of severe Covid-19

Nature Communications(2021)10.1038/s41467-021-26138-6

N/A

0DataRank · unranked

140 citations

Youngil Koh, Michael B. Foote, Hogune Im, Justin Jee, Choong Hyun Sun +40 more

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1134

N/A

0DataRank · unranked

73 citations

Pier Selenica, Juber Patel, Michelle Wu, Josip Ninčević, Yulia Lakhman +25 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0DataRank · unranked

73 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Nature Communications(2022)10.1038/s41467-022-34109-8

N/A

0DataRank · unranked

56 citations

Alison M. Schram, Ezra Y. Rosen, Helen Won, Yixiao Gong, Anne Marie Noronha +11 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2022.01.011

N/A

0DataRank · unranked

33 citations

Anita S. Bowman, Sumit Middha, Kseniya Petrova‐Drus, Yi‐Wei Tang, Xin Chen +12 more

Diverse alterations associated with resistance to KRAS(G12C) inhibition

Nature(2021)10.1038/s41586-021-04065-2

N/A

0DataRank · unranked

452 citations

Yonina R. Murciano‐Goroff, Jenny Y. Xue, Agnes Ang, Jessica Lucas, Trang T. Mai +23 more

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

npj Breast Cancer(2022)10.1038/s41523-022-00470-6

N/A

0DataRank · unranked

25 citations

Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng +21 more

Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1527

N/A

0DataRank · unranked

1 citations

Erin Salo‐Mullen, Amanda Catchings, Megha Ranganathan, Elise Fiala, Yelena Kemel +15 more

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4016

N/A

0DataRank · unranked

15 citations

Samuel C. Nussenzweig, Henry S. Walch, Meier Hsu, Kay See Tan, Sergio De La Torre +13 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0DataRank · unranked

14 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Effects of radiation therapy on clonal hematopoiesis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12062

N/A

0DataRank · unranked

1 citations

N. Ari Wijetunga, Minal Patel, Teng Gao, Ryan Ptashkin, Michael R Sullivan +12 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

medRxiv(2022)10.1101/2022.10.03.22280675

N/A

0DataRank · unranked

1 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

Research Square(2022)10.21203/rs.3.rs-2094202/v1

N/A

0DataRank · unranked

0 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Clonal hematopoiesis is associated with risk of severe Covid-19

medRxiv(2020)10.1101/2020.11.25.20233163

N/A

0DataRank · unranked

29 citations

Youngil Koh, Michael B. Foote, Hogune Im, Justin Jee, Choong Hyun Sun +38 more

Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0865

N/A

0DataRank · unranked

31 citations

Brooke E. Sylvester, Matthew T. Chang, Arijh Elzein, Jianjiong Gao, Weiwei Han +24 more

Genomic mapping of metastatic organotropism in lung adenocarcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.018

N/A

0DataRank · unranked

90 citations

Brooke Mastrogiacomo, James G. Connolly, Kay See Tan, Yuan Liu, Cameron N. Fick +22 more

Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2892

N/A

0DataRank · unranked

48 citations

Jinru Shia, Zalak Patel, Diane Reidy‐Lagunes, Neil H. Segal, Rona Yaeger +20 more

Protein-altering germline mutations implicate novel genes related to lung cancer development

Nature Communications(2020)10.1038/s41467-020-15905-6

N/A

0DataRank · unranked

49 citations

Semanti Mukherjee, Maria Teresa Landi, Yohan Bossé, Philippe Joubert, Dakai Zhu +95 more

Fragment Size Analysis May Distinguish Clonal Hematopoiesis from Tumor-Derived Mutations in Cell-Free DNA

Clinical Chemistry(2020)10.1093/clinchem/hvaa026

N/A

0DataRank · unranked

50 citations

Dennis Stephens, Ryan Ptashkin, Ahmet Zehir, Michael F. Berger, David B. Solit +3 more

Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma

Journal of Clinical Oncology(2023)10.1200/jco.23.00561

N/A

0DataRank · unranked

44 citations

Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu +30 more

Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade

Nature Medicine(2023)10.1038/s41591-023-02544-9

N/A

0DataRank · unranked

38 citations

Michael B. Foote, Benoı̂t Rousseau, Henry Walch, Yelena Kemel, Allison L. Richards +33 more

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

Cancer Cell(2023)10.1016/j.ccell.2023.10.003

N/A

0DataRank · unranked

36 citations

Dexter X. Jin, Justin Y. Newberg, Tomin Perea-Chamblee, Kelly R. Pekala, Christopher J. Fong +21 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications(2023)10.1038/s41467-023-42585-9

N/A

0DataRank · unranked

29 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1078

N/A

0DataRank · unranked

20 citations

Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos +17 more

Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors

JCO Precision Oncology(2023)10.1200/po.23.00070

N/A

0DataRank · unranked

19 citations

Miika Mehine, Ryan Ptashkin, Kelly L. Bolton, Chaitanya Bandlamudi, Preethi Srinivasan +18 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016

N/A

0DataRank · unranked

21 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.11.019

N/A

0DataRank · unranked

19 citations

Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Sia +23 more

Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma

JCO Precision Oncology(2023)10.1200/po.23.00272

N/A

0DataRank · unranked

18 citations

Jessica White, Joanne F. Chou, Pin‐Jung Chen, Tae‐Hyung Kim, Danny N. Khalil +17 more

Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma

Modern Pathology(2023)10.1016/j.modpat.2023.100150

N/A

0DataRank · unranked

16 citations

Bin Xu, Satshil Rana, Hui Chen, Ronald Ghossein, Michael F. Berger +3 more

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry

Cancer(2023)10.1002/cncr.35071

N/A

0DataRank · unranked

14 citations

Sushmita Gordhandas, Kanika Arora, Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings +26 more

High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer

Blood Advances(2023)10.1182/bloodadvances.2023011262

N/A

0DataRank · unranked

13 citations

Kamal Menghrajani, Sean M. Devlin, Sebastià Franch‐Expósito, Ryan Ptashkin, Swara Y. Patel +13 more

Genomic ancestry in kidney cancer: Correlations with clinical and molecular features

Cancer(2023)10.1002/cncr.35074

N/A

0DataRank · unranked

12 citations

Andrea Knežević, Kanika Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria I. Carlo +12 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024

N/A

0DataRank · unranked

8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3322

N/A

0DataRank · unranked

45 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Deep Learning Model for Tumor Type Prediction using Targeted Clinical Genomic Sequencing Data

medRxiv(2023)10.1101/2023.09.08.23295131

N/A

0DataRank · unranked

4 citations

Shalabh Suman, Gurnit Atwal, Jie‐Fu Chen, Jason C. Chang, Michael Toomey +8 more

ctDNA analysis of NTRK fusion and mechanisms of acquired resistance to TRK inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3062

N/A

0DataRank · unranked

2 citations

Guilherme Harada, Noura J. Choudhury, Casey Savin, Ronak Shah, Michael F. Berger +2 more

Clonal hematopoiesis in survivors of childhood cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10014

N/A

0DataRank · unranked

1 citations

Irenaeus C.C. Chan, Chaya S. Moskowitz, Shanita Li, Kimberly L. Turner, Jie Liu +15 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways

(2023)10.1158/1078-0432.c.6529997.v1

Top 100%

0DataRank

Top 100%0 citations

Samuel C. Nussenzweig, Henry Walch, Meier Hsu, Kay See Tan, Francisco Sánchez-Vega +16 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10511

N/A

0DataRank · unranked

0 citations

Semanti Mukherjee, Ming Gao, Elise Fiala, Audrey Mauguen, Yelena Kemel +14 more

Large-scale clinicogenomic models of solid tumor CNS metastasis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2037

N/A

0DataRank · unranked

0 citations

Anisha Luthra, Christopher J. Fong, Karl Pichotta, Thinh Ngoc Tran, Mirella L. Altoé +15 more

Pathogenic germline variants in patients with endometrial cancer across diverse ancestries.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5596

N/A

0DataRank · unranked

0 citations

Sushmita Gordhandas, Kanika Arora, Anna Maio, Yelena Kemel, Margaret Sheehan +15 more

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1559

N/A

0DataRank · unranked

0 citations

Andrew Schroeder, Subrata Chatterjee, John Cadley, Christina J. Falcon, Miika Mehine +15 more

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0571

N/A

0DataRank · unranked

70 citations

Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman +29 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0DataRank · unranked

54 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Chromothripsis-Mediated Small Cell Lung Carcinoma

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0286

N/A

0DataRank · unranked

45 citations

Sam E. Tischfield, Christopher A. Febres‐Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin Herzberg +37 more

Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing Data

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0996

N/A

0DataRank · unranked

27 citations

Shalabh Suman, Gurnit Atwal, Michael Toomey, Jie‐Fu Chen, Jason C. Chang +8 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4

N/A

0DataRank · unranked

20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

Haematologica(2024)10.3324/haematol.2024.285055

N/A

0DataRank · unranked

10 citations

Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer A. Kennedy, Zarina Yelskaya +40 more

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy

The Oncologist(2024)10.1093/oncolo/oyae110

N/A

0DataRank · unranked

5 citations

Joanne F. Chou, Henry Walch, Fergus Keane, Danny N. Khalil, Jinru Shia +20 more

Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies

Haematologica(2024)10.3324/haematol.2024.285054

N/A

0DataRank · unranked

9 citations

Kseniya Petrova‐Drus, Ryan Ptashkin, Mark D. Ewalt, JinJuan Yao, Ying Liu +43 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0DataRank · unranked

4 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Analysis of Shared Variants between Cancer Biospecimens

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1583

N/A

0DataRank · unranked

2 citations

James R. White, Walid K. Chatila, Guillem Argilés, Steve Lu, Benoı̂t Rousseau +15 more

Non-RB1 germline cancer predisposing variants found in retinoblastoma patients

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101836

N/A

0DataRank · unranked

1 citations

Michael F. Walsh, Melissa A. Robbins, Audrey Mauguen, Elise Fiala, Cristina Olcese +8 more

Differences in Ancestry and Presence of Gastric Precursor Lesions in Individuals With Young‐ and Average‐Onset Gastric Cancer

Cancer Medicine(2024)10.1002/cam4.70451

N/A

0DataRank · unranked

1 citations

Nicole Cornet, Laura H. Tang, Kanika Arora, Neha Hingorani, Stephanie King +15 more

Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.21.609031

N/A

0DataRank · unranked

7 citations

Ignacio Vázquez-Garćıa, Grittney Tam, Michelle Wu, Nancy Varice, Eliyahu Havasov +22 more

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0418

N/A

0DataRank · unranked

227 citations

Jiapeng Chen, Joanne F. Chou, Anna M. Varghese, Kenneth H. Yu, Winston Wong +26 more

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling – A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACT

Research Square(2024)10.21203/rs.3.rs-4746484/v1

N/A

0DataRank · unranked

0 citations

Chad Vanderbilt, Soo‐Ryum Yang, Subhiksha Nandakumar, Khédoudja Nafa, Rusmir Feratovic +10 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Nature Medicine(2025)10.1038/s41591-024-03362-3

N/A

0DataRank · unranked

75 citations

Maria Perry, Joanne F. Chou, Subhiksha Nandakumar, Daniel M. Muldoon, Amanda Erakky +24 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0DataRank · unranked

22 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

Nature Genetics(2025)10.1038/s41588-025-02250-x

N/A

0DataRank · unranked

19 citations

Duc Tran, Liying Xue, Brian J. Wiley, Caitlyn Vlasschaert, Caroline J. Watson +36 more

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Nature Communications(2025)10.1038/s41467-025-67643-2

N/A

0DataRank · unranked

6 citations

Xinran Tang, Jordan Eichholz, Andrew McPherson, Jasmine Thomas, Karan Nagar +23 more

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling

Nature Communications(2025)10.1038/s41467-024-55456-8

N/A

0DataRank · unranked

5 citations

Chad Vanderbilt, Soo‐Ryum Yang, Subhiksha Nandakumar, Khédoudja Nafa, Rusmir Feratovic +10 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010

N/A

0DataRank · unranked

5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf139

N/A

0DataRank · unranked

4 citations

Lily V. Saadat, Catherine O’Connor, Joanne F. Chou, Anita S. Bowman, Fei Xu +18 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors

Clinical and Translational Medicine(2025)10.1002/ctm2.70338

N/A

0DataRank · unranked

3 citations

Valentina Foglizzo, Jason Chang, Natasha Rekhtman, Ann Elizabeth Sisk, Jamie Gibson +20 more

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors

Acta Neuropathologica(2025)10.1007/s00401-025-02935-x

N/A

0DataRank · unranked

2 citations

Miika Mehine, Yelena Kemel, Chaitanya Bandlamudi, Diana Mandelker, Marc K. Rosenblum +36 more

Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3910

N/A

0DataRank · unranked

1 citations

Tara J. O’Donohue, Tejus Bale, Anita S. Bowman, Katherine E. Hill, Emily Stockfisch +20 more

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma

Ophthalmology Science(2021)10.1016/j.xops.2021.100015

N/A

0DataRank · unranked

33 citations

Diana Mandelker, Jasmine H. Francis, Ira J. Dunkel, A. Rose Brannon, Ryma Benayed +13 more

Michael F. Berger

Indexed papers

Top data-sharing exemplar

Papers